Expression Profile of Galectin-1 and Galectin-3 Molecules in Different Subtypes of Chronic Lymphocytic Leukemia

REFERENCES

• Houzelstein, D.; Goncalves, I.R.; Fadden, A.J.; Sidhu, S.S.; Cooper, D.N.; Drickamer, K.; Leffler, H.; Poirier, F. Phylogenetic analysis of the vertebrate galectin family. Mol Biol Evol 2004, 21(7), 1177–1187.
   PubMed Web of Science ®Google Scholar
• Leffler, H.; Carlsson, S.; Hedlund, M.; Qian, Y.; Poirier, F. Introduction to galectins. Glycoconj J 2004, 19(7–9), 433–440.
   PubMed Web of Science ®Google Scholar
• Rabinovich, G.A.; Toscano, M.A.; Jackson, S.S.; Vasta, G.R. Functions of cell surface galectin-glycoprotein lattices. Curr Opin Struct Biol 2007, 17(5), 513–520.
   PubMed Web of Science ®Google Scholar
• Dumic, J.; Dabelic, S.; Flogel, M. Galectin-3: an open-ended story. Biochim Biophys Acta 2006, 1760(4), 616–635.
   PubMed Web of Science ®Google Scholar
• Krzeslak, A.; Lipinska, A. Galectin-3 as a multifunctional protein. Cell Mol Biol Lett 2004, 9(2), 305–328.
   PubMed Web of Science ®Google Scholar
• Perillo, N.L.; Marcus, M.E.; Baum, L.G. Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death. J Mol Med 1998, 76(6), 402–412.
   PubMed Web of Science ®Google Scholar
• Davidson, P.J.; Davis, M.J.; Patterson, R.J.; Ripoche, M.A.; Poirier, F.; Wang, J.L. Shuttling of galectin-3 between the nucleus and cytoplasm. Glycobiology 2002, 12(5), 329–337.
   PubMed Web of Science ®Google Scholar
• Liu, F.T. Regulatory roles of galectins in the immune response. Int Arch Allergy Immunol 2005, 136(4), 385–400.
   PubMed Web of Science ®Google Scholar
• Nakahara, S.; Oka, N.; Raz, A. On the role of galectin-3 in cancer apoptosis. Apoptosis 2005, 10(2), 267–275.
   PubMed Web of Science ®Google Scholar
• Seelenmeyer, C.; Wegehingel, S.; Tews, I.; Kunzler, M.; Aebi, M.; Nickel, W. Cell surface counter receptors are essential components of the unconventional export machinery of galectin-1. J Cell Biol 2005, 171(2), 373–381.
   PubMed Web of Science ®Google Scholar
• Camby, I.; Le Mercier, M.; Lefranc, F.; Kiss, R. Galectin-1: a small protein with major functions. Glycobiology 2006, 16(11), 137R–157R.
   PubMed Web of Science ®Google Scholar
• Fred Brewer, C. Binding and cross-linking properties of galectins. Biochim Biophys Acta 2002, 1572(2–3), 255–262.
   PubMed Web of Science ®Google Scholar
• Lahm, H.; Andre, S.; Hoeflich, A.; Kaltner, H.; Siebert, H.C.; Sordat, B.; von der Lieth, C.W.; Wolf, E.; Gabius, H.J. Tumor galectinology: insights into the complex network of a family of endogenous lectins. Glycoconj J 2004, 20(4), 227–238.
   PubMed Web of Science ®Google Scholar
• Hojjat-Farsangi, M.; Jeddi-Tehrani, M.; Razavi, S.M.; Sharifian, R.A.; Mellstedt, H.; Shokri, F.; Rabbani, H. Immunoglobulin heavy chain variable region gene usage and mutational status of the leukemic B cells in Iranian patients with chronic lymphocytic leukemia. Cancer Sci 2009, 100(12), 2346–2353.
   PubMed Web of Science ®Google Scholar
• Dighiero, G. CLL biology and prognosis. Hematology Am Soc Hematol Educ Program 2005, 1, 278–284.
   Google Scholar
• Gharagozlou, S.; Ghods, R.; Bahrami, Z.S.; Roohi, A.; Jeddi-Tehrani, M.; Conti-Fine, B.M.; Sharifian, R.A.; Rabbani, H.; Shokri, F. Characterization of human hybridoma clones isolated from hemophilia patients with specificity for different domains of coagulating factor VIII. Hum Antibodies 2003, 12(3), 67–76.
   PubMedGoogle Scholar
• Kiwaki, K.; Novak, C.M.; Hsu, D.K.; Liu, F.T.; Levine, J.A. Galectin-3 stimulates preadipocyte proliferation and is up-regulated in growing adipose tissue. Obesity (Silver Spring) 2007, 15(1), 32–39.
   PubMed Web of Science ®Google Scholar
• Huang, C.; Yang, L.; Li, Z.; Yang, J.; Zhao, J.; Dehui, X.; Liu, L.; Wang, Q.; Song, T. Detection of CCND1 amplification using laser capture microdissection coupled with real-time polymerase chain reaction in human esophageal squamous cell carcinoma. Cancer Genet Cytogenet 2007, 175(1), 19–25.
   PubMed Web of Science ®Google Scholar
• Kazemi, T.; Asgarian-Omran, H.; Memarian, A.; Shabani, M.; Sharifian, R.A.; Vossough, P.; Ansaripour, B.; Rabbani, H.; Shokri, F. Low representation of Fc receptor-like 1–5 molecules in leukemic cells from Iranian patients with acute lymphoblastic leukemia. Cancer Immunol Immunother 2009, 58(6), 989–996.
   PubMed Web of Science ®Google Scholar
• Kazemi, T.; Asgarian-Omran, H.; Hojjat-Farsangi, M.; Shabani, M.; Memarian, A.; Sharifian, R.A.; Razavi, S.M.; Jeddi-Tehrani, M.; Rabbani, H.; Shokri, F. Fc receptor-like 1–5 molecules are similarly expressed in progressive and indolent clinical subtypes of B-cell chronic lymphocytic leukemia. Int J Cancer 2008, 123(9), 2113–2119.
   PubMed Web of Science ®Google Scholar
• Asgarian Omran, H.; Shabani, M.; Vossough, P.; Sharifian, R.; Tabrizi, M.; Khoshnoodi, J.; Jeddi-Tehrani, M.; Rabbani, H.; Shokri, F. Cross-sectional monitoring of Wilms’ tumor gene 1 (WT1) expression in Iranian patients with acute lymphoblastic leukemia at diagnosis, relapse and remission. Leuk Lymphoma 2008, 49(2), 281–290.
   PubMed Web of Science ®Google Scholar
• Eude-Le Parco, I.; Gendronneau, G.; Dang, T.; Delacour, D.; Thijssen, V.L.; Edelmann, W.; Peuchmaur, M.; Poirier, F. Genetic assessment of the importance of galectin-3 in cancer initiation, progression, and dissemination in mice. Glycobiology 2009, 19(1), 68–75.
   PubMed Web of Science ®Google Scholar
• Matsuda, Y.; Yamagiwa, Y.; Fukushima, K.; Ueno, Y.; Shimosegawa, T. Expression of galectin-3 involved in prognosis of patients with hepatocellular carcinoma. Hepatol Res 2008, 38(11), 1098–1111.
   PubMed Web of Science ®Google Scholar
• Junking, M.; Wongkham, C.; Sripa, B.; Sawanyawisuth, K.; Araki, N.; Wongkham, S. Decreased expression of galectin-3 is associated with metastatic potential of liver fluke-associated cholangiocarcinoma. Eur J Cancer 2008, 44(4), 619–626.
   PubMed Web of Science ®Google Scholar
• Tsuboi, K.; Shimura, T.; Masuda, N.; Ide, M.; Tsutsumi, S.; Yamaguchi, S.; Asao, T.; Kuwano, H. Galectin-3 expression in colorectal cancer: relation to invasion and metastasis. Anticancer Res 2007, 27(4B), 2289–2296.
   PubMed Web of Science ®Google Scholar
• Prieto, V.G.; Mourad-Zeidan, A.A.; Melnikova, V.; Johnson, M.M.; Lopez, A.; Diwan, A.H.; Lazar, A.J.; Shen, S.S.; Zhang, P.S.; Reed, J.A.; Gershenwald, J.E.; Raz, A.; Bar-Eli, M. Galectin-3 expression is associated with tumor progression and pattern of sun exposure in melanoma. Clin Cancer Res 2006, 12(22), 6709–6715.
   PubMed Web of Science ®Google Scholar
• Takenaka, Y.; Fukumori, T.; Raz, A. Galectin-3 and metastasis. Glycoconj J 2004, 19(7–9), 543–549.
   PubMed Web of Science ®Google Scholar
• Califice, S.; Castronovo, V.; Van Den Brule, F. Galectin-3 and cancer [Review]. Int J Oncol 2004, 25(4), 983–992.
   PubMed Web of Science ®Google Scholar
• Hittelet, A.; Legendre, H.; Nagy, N.; Bronckart, Y.; Pector, J.C.; Salmon, I.; Yeaton, P.; Gabius, H.J.; Kiss, R.; Camby, I. Upregulation of galectins-1 and -3 in human colon cancer and their role in regulating cell migration. Int J Cancer 2003, 103(3), 370–379.
   PubMed Web of Science ®Google Scholar
• Van Den Brule, F.A.; Waltregny, D.; Liu, F.T.; Castronovo, V. Alteration of the cytoplasmic/nuclear expression pattern of galectin-3 correlates with prostate carcinoma progression. Int J Cancer 2000, 89(4), 361–367.
   PubMed Web of Science ®Google Scholar
• Kawachi, K.; Matsushita, Y.; Yonezawa, S.; Nakano, S.; Shirao, K.; Natsugoe, S.; Sueyoshi, K.; Aikou, T.; Sato, E. Galectin-3 expression in various thyroid neoplasms and its possible role in metastasis formation. Hum Pathol 2000, 31(4), 428–433.
   PubMed Web of Science ®Google Scholar
• Nakamura, M.; Inufusa, H.; Adachi, T.; Aga, M.; Kurimoto, M.; Nakatani, Y.; Wakano, T.; Nakajima, A.; Hida, J.I.; Miyake, M.; Shindo, K.; Yasutomi, M. Involvement of galectin-3 expression in colorectal cancer progression and metastasis. Int J Oncol 1999, 15(1), 143–148.
   PubMed Web of Science ®Google Scholar
• Castronovo, V.; Van Den Brule, F.A.; Jackers, P.; Clausse, N.; Liu, F.T.; Gillet, C.; Sobel, M.E. Decreased expression of galectin-3 is associated with progression of human breast cancer. J Pathol 1996, 179(1), 43–48.
   PubMed Web of Science ®Google Scholar
• Lotan, R.; Ito, H.; Yasui, W.; Yokozaki, H.; Lotan, D.; Tahara, E. Expression of a 31-kDa lactoside-binding lectin in normal human gastric mucosa and in primary and metastatic gastric carcinomas. Int J Cancer 1994, 56(4), 474–480.
   PubMed Web of Science ®Google Scholar
• Mollenhauer, J.; Deichmann, M.; Helmke, B.; Muller, H.; Kollender, G.; Holmskov, U.; Ligtenberg, T.; Krebs, I.; Wiemann, S.; Bantel-Schaal, U.; Madsen, J.; Bikker, F.; Klauck, S.M.; Otto, H.F.; Moldenhauer, G.; Poustka, A. Frequent downregulation of DMBT1 and galectin-3 in epithelial skin cancer. Int J Cancer 2003, 105(2), 149–157.
   PubMed Web of Science ®Google Scholar
• Van Den Brule, F.A.; Buicu, C.; Berchuck, A.; Bast, R.C.; Deprez, M.; Liu, F.T.; Cooper, D.N.; Pieters, C.; Sobel, M.E.; Castronovo, V. Expression of the 67-kD laminin receptor, galectin-1, and galectin-3 in advanced human uterine adenocarcinoma. Hum Pathol 1996, 27(11), 1185–1191.
   PubMed Web of Science ®Google Scholar
• Lee, J.W.; Song, S.Y.; Choi, J.J.; Choi, C.H.; Kim, T.J.; Kim, J.; Lee, J.H.; Kim, B.G.; Bae, D.S. Decreased galectin-3 expression during the progression of cervical neoplasia. J Cancer Res Clin Oncol 2006, 132(4), 241–247.
   PubMed Web of Science ®Google Scholar
• Kramer, M.W.; Kuczyk, M.A.; Hennenlotter, J.; Serth, J.; Schilling, D.; Stenzl, A.; Merseburger, A.S. Decreased expression of galectin-3 predicts tumour recurrence in pTa bladder cancer. Oncol Rep 2008, 20(6), 1403–1408.
   PubMed Web of Science ®Google Scholar
• Okada, K.; Shimura, T.; Suehiro, T.; Mochiki, E.; Kuwano, H. Reduced galectin-3 expression is an indicator of unfavorable prognosis in gastric cancer. Anticancer Res 2006, 26(2B), 1369–1376.
   PubMed Web of Science ®Google Scholar
• Turkoz, H.K.; Oksuz, H.; Yurdakul, Z.; Ozcan, D. Galectin-3 expression in tumor progression and metastasis of papillary thyroid carcinoma. Endocr Pathol 2008, 19(2), 92–96.
   PubMed Web of Science ®Google Scholar
• Califice, S.; Castronovo, V.; Bracke, M.; Van Den Brule, F. Dual activities of galectin-3 in human prostate cancer: tumor suppression of nuclear galectin-3 vs tumor promotion of cytoplasmic galectin-3. Oncogene 2004, 23(45), 7527–7536.
   PubMed Web of Science ®Google Scholar
• Saussez, S.; Decaestecker, C.; Mahillon, V.; Cludts, S.; Capouillez, A.; Chevalier, D.; Vet, H.K.; André, S.; Toubeau, G.; Leroy, X.; Gabius, H.J. Galectin-3 upregulation during tumor progression in head and neck cancer. Laryngoscope 2008, 118(9), 1583–1590.
   PubMed Web of Science ®Google Scholar
• Zubieta, M.R.; Furman, D.; Barrio, M.; Bravo, A.I.; Domenichini, E.; Mordoh, J. Galectin-3 expression correlates with apoptosis of tumor-associated lymphocytes in human melanoma biopsies. Am J Pathol 2006, 168(5), 1666–1675.
   PubMed Web of Science ®Google Scholar
• Stowell, S.R.; Qian, Y.; Karmakar, S.; Koyama, N.S.; Dias-Baruffi, M.; Leffler, H.; McEver, R.P.; Cummings, R.D. Differential roles of galectin-1 and galectin-3 in regulating leukocyte viability and cytokine secretion. J Immunol 2008, 180(5), 3091–3102.
   PubMed Web of Science ®Google Scholar
• Chiariotti, L.; Berlingieri, M.T.; Battaglia, C.; Benvenuto, G.; Martelli, M.L.; Salvatore, P.; Chiappetta, G.; Bruni, C.B.; Fusco, A. Expression of galectin-1 in normal human thyroid gland and in differentiated and poorly differentiated thyroid tumors. Int J Cancer 1995, 64(3), 171–175.
   PubMed Web of Science ®Google Scholar
• Van Den Brule, F.A.; Waltregny, D.; Castronovo, V. Increased expression of galectin-1 in carcinoma-associated stroma predicts poor outcome in prostate carcinoma patients. J Pathol 2001, 193(1), 80–87.
   PubMed Web of Science ®Google Scholar
• Van Den Brule, F.; Califice, S.; Garnier, F.; Fernandez, P.L.; Berchuck, A.; Castronovo, V. Galectin-1 accumulation in the ovary carcinoma peritumoral stroma is induced by ovary carcinoma cells and affects both cancer cell proliferation and adhesion to laminin-1 and fibronectin. Lab Invest 2003, 83(3), 377–386.
   PubMed Web of Science ®Google Scholar
• Strik, H.M.; Schmidt, K.; Lingor, P.; Tonges, L.; Kugler, W.; Nitsche, M.; Rabinovich, G.A.; Bähr, M. Galectin-1 expression in human glioma cells: modulation by ionizing radiation and effects on tumor cell proliferation and migration. Oncol Rep 2007, 18(2), 483–488.
   PubMed Web of Science ®Google Scholar
• Jung, E.J.; Moon, H.G.; Cho, B.I.; Jeong, C.Y.; Joo, Y.T.; Lee, Y.J.; Hong, S.C.; Choi, S.K.; Ha, W.S.; Kim, J.W.; Lee, C.W.; Lee, J.S.; Park, S.T. Galectin-1 expression in cancer-associated stromal cells correlates tumor invasiveness and tumor progression in breast cancer. Int J Cancer 2007, 120(11), 2331–2338.
   PubMed Web of Science ®Google Scholar
• Jung, T.Y.; Jung, S.; Ryu, H.H.; Jeong, Y.I.; Jin, Y.H.; Jin, S.G.; Kim, I.Y.; Kang, S.S.; Kim, H.S. Role of galectin-1 in migration and invasion of human glioblastoma multiforme cell lines. J Neurosurg 2008, 109(2), 273–284.
   PubMed Web of Science ®Google Scholar
• Wu, M.H.; Hong, T.M.; Cheng, H.W.; Pan, S.H.; Liang, Y.R.; Hong, H.C.; Chiang, W.F.; Wong, T.Y.; Shieh, D.B.; Shiau, A.L.; Jin, Y.T.; Chen, Y.L. Galectin-1-mediated tumor invasion and metastasis, up-regulated matrix metalloproteinase expression, and reorganized actin cytoskeletons. Mol Cancer Res 2009, 7(3), 311–318.
   PubMed Web of Science ®Google Scholar
• Ilarregui, J.M.; Croci, D.O.; Bianco, G.A.; Toscano, M.A.; Salatino, M.; Vermeulen, M.E.; Geffner, J.R.; Rabinovich, G.A. Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10. Nat Immunol 2009, 10(9), 981–991.
   PubMed Web of Science ®Google Scholar
• Thijssen, V.L.; Postel, R.; Brandwijk, R.J.; Dings, R.P.; Nesmelova, I.; Satijn, S.; Verhofstad, N.; Nakabeppu, Y.; Baum, L.G.; Bakkers, J.; Mayo, K.H.; Poirier, F.; Griffioen, A.W. Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy. Proc Natl Acad Sci U S A 2006, 103(43), 15975–15980.
   PubMed Web of Science ®Google Scholar
• Iurisci, I.; Cumashi, A.; Sherman, A.A.; Tsvetkov, Y.E.; Tinari, N.; Piccolo, E.; D'Egidio, M.; Adamo, V.; Natoli, C.; Rabinovich, G.A.; Iacobelli, S.; Nifantiev, N.E.; Consorzio Interuniversitario Nazionale Per la Bio-Oncologia. Synthetic inhibitors of galectin-1 and -3 selectively modulate homotypic cell aggregation and tumor cell apoptosis. Anticancer Res 2009, 29(1), 403–410.
   PubMed Web of Science ®Google Scholar